Listen

 

Watch

Join Michael McDermott, M.D., chief medical executive of Baptist Health Miami Neuroscience Institute, and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience, along with Manmeet Ahluwalia, M.D., MBA, FASCO, the chief of medical oncology, chief scientific officer & deputy director, and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute, as they discuss a prospective clinical trial on the use of low intensity focused ultrasound for non-small cell lung cancer brain metastases, gender distribution, previous treatment results, and overall survival.


Created by

Baptist Health South Florida

Related Presenters

Michael W. McDermott, M.D.

Michael W. McDermott, M.D.

Chief Medical Executive, Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience

Michael McDermott, M.D., is a neurosurgeon and the chief medical executive of Miami Neuroscience Institute. He is a world-renowned leader in neurosciences and has clinical expertise in the field of meningioma surgery and Gamma Knife radiosurgery.  

View full profile

Manmeet Ahluwalia, M.D., MBA, FASCO

Manmeet Ahluwalia, M.D., MBA, FASCO

Chief of Medical Oncology, Chief Scientific Officer & Deputy Director, Fernandez Family Endowed Chair in Cancer Research Baptist Health Miami Cancer Institute

Manmeet Ahluwalia, M.D., MBA, FASCO, is the chief scientific officer, chief of medical oncology, deputy director and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute.

View full profile